IPHA (Innate Pharma S.A.) יחס שווי שוק לשווי בספרים
Innate Pharma S.A. (IPHA) leverages the expertise of French immunologists who value academic freedom and prestige within the biotech sector. High trust from the global community has cemented the brand's status as an authoritative drug developer. The market dynamics reflected in the price action captured the -2.99 metric. Innate Pharma S.A. (IPHA) leads the development of NK-cell therapies, utilizing the ANKET system to create antibodies that gently activate the body's defenses against tumors.
פילוחי מדדים פיננסיים ומדדי שוק עבור Innate Pharma SA (IPHA)
This indicator determines the proportionality of the market value of Innate Pharma S.A. (IPHA) to its net book value, reflecting the premium or discount to real capital through the ratio of share prices to balance sheet data. Analyzing the ratio of the company's market capitalization to its book capitalization allows for an assessment of the value of its intellectual property, including the unique ANKET platform and long-term licensing agreements with global pharma behemoths.